David T.

David T. is an experienced professional who has held various roles in clinical research and program management at companies such as Scribe Therapeutics, Graphite Bio, and Global Blood Therapeutics. David has also served as a speaker and session chair at the MAGI Clinical Research Conference and as a member of Pfizer's Sickle Cell Advisory Board. David T. holds a Bachelors of Science degree in Exercise Biology from the University of California, Davis.